{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:01:55Z","timestamp":1790899315394,"version":"4.1.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Nerve growth factor (NGF) is upregulated in psoriatic skin, and increasing evidence indicates that its receptor, p75 neurotrophin receptor (p75NTR), promotes inflammatory responses. However, the contribution of p75NTR and its ligand, pro-nerve growth factor (proNGF), in psoriasis inflammation remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To investigate the role of p75NTR in the inflammatory response of skin fibroblasts derived from plaques from patients with psoriasis, to unravel possible novel interactions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Plasma levels of proNGF and p75NTR extracellular domain (ECD) were measured in 54 patients with psoriasis and 25 healthy donors (HDs). p75NTR and tropomyosin receptor kinase A expression were evaluated in skin biopsies and dermal fibroblasts from patients with psoriasis and from HDs. Protein\u2013protein interaction (PPI) analysis was used to prioritize potential p75NTR interactors. The effects of cytokines related to psoriasis [interferon (IFN)-\u03b3, tumour necrosis factor (TNF)-\u03b1, interleukin (IL)-22, IL-17A] on receptor expression were examined in skin biopsies and fibroblasts. Pharmacological inhibition of p75NTR with LM11A-31 (p75i) or RNA interference was used to assess effects on intracellular signalling, inflammatory gene expression (IL6, PTGS2, CCL2, CCL20) and molecular interactions using reverse transcription quantitative polymerase chain reaction, Western blotting, enzyme-linked immunosorbent assay and proximity ligation assay (PLA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>p75NTR expression was increased in the dermal layer of skin biopsies from psoriasis plaques, and plasma levels of p75NTR ECD and proNGF were enhanced in patients with psoriasis and correlated with disease severity. Psoriasis fibroblasts showed high basal p75NTR expression, which was inducible by the cytokine mix (IFN-\u03b3, TNF-\u03b1, IL-22, IL-17A) in HD fibroblasts and blocked by LM11A-31. In fibroblasts from HDs and from patients with psoriasis, p75NTR inhibition significantly reduced cytokine-induced inflammatory gene expression and prevented nuclear translocation of nuclear factor-\u03baB. Similar effects were seen after inhibition of Toll-like receptor 4 (TLR4). PPI analysis identified the alarmins high mobility group box 1 (HMGB1) and nucleophosmin as potential connectors between p75NTR and TLR4. These interactions were confirmed by PLA. Treatment with the cytokine mix enhanced p75NTR\u2013TLR4\u2013alarmin interactions, which were prevented by the p75i. Moreover, nucleophosmin and HMGB1 inhibition decreased p75NTR\u2013TLR4 interaction and inflammatory gene expression. In psoriasis fibroblasts, p75NTR inhibition consistently reduced cytokine mix or lipopolysaccharide-induced extracellular release of nucleophosmin and HMGB1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>p75NTR upregulation and signalling contribute to alarmin release and amplification of the TLR4\u2013NF-\u03baB inflammatory pathway in psoriasis. p75NTR can be considered a sensor of inflammation required for full activation of TLR4-dependent inflammatory signalling. Thus, p75NTR targeting may represent a novel therapeutic strategy to counteract chronic inflammation in psoriasis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/bjd\/ljag152","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T11:37:07Z","timestamp":1776339427000},"page":"122-135","source":"Crossref","is-referenced-by-count":2,"title":["Nerve growth factor receptor p75NTR interacts with Toll-like receptor 4 and the alarmins high mobility group box\u00a01 and nucleophosmin: a novel inflammatory mechanism in psoriasis"],"prefix":"10.1093","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2036-2071","authenticated-orcid":false,"given":"Sara","family":"Sileno","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Regenerative Medicine, Istituto Dermopatico dell\u2019Immacolata, IDI-IRCCS , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7682-6357","authenticated-orcid":false,"given":"Marco","family":"D\u2019Agostino","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Regenerative Medicine, Istituto Dermopatico dell\u2019Immacolata, IDI-IRCCS , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8304-541X","authenticated-orcid":false,"given":"Luciapia","family":"Farina","sequence":"additional","affiliation":[{"name":"Department of Immunology, Laboratory of Immuno-Rheumatology, Bambino Ges\u00f9 Children's Hospital, IRCCS , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9094-0343","authenticated-orcid":false,"given":"Andrea","family":"Kosta","sequence":"additional","affiliation":[{"name":"Department of Immunology, Laboratory of Immuno-Rheumatology, Bambino Ges\u00f9 Children's Hospital, IRCCS , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7844-6836","authenticated-orcid":false,"given":"Luigi","family":"Manni","sequence":"additional","affiliation":[{"name":"Institute of Translational Pharmacology (IFT), National Research Council of Italy (CNR) , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1420-0914","authenticated-orcid":false,"given":"Marzia","family":"Soligo","sequence":"additional","affiliation":[{"name":"Institute of Translational Pharmacology (IFT), National Research Council of Italy (CNR) , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0629-1729","authenticated-orcid":false,"given":"Laura","family":"Mercurio","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Immunology , IDI-IRCCS, Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0585-6783","authenticated-orcid":false,"given":"Stefania","family":"Madonna","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Immunology , IDI-IRCCS, Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7537-6833","authenticated-orcid":false,"given":"Cristina","family":"Albanesi","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Immunology , IDI-IRCCS, Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabatino","family":"Pallotta","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Istituto Dermopatico dell'Immacolata (IDI-IRCCS) , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8839-5961","authenticated-orcid":false,"given":"Gaia","family":"Moretta","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Istituto Dermopatico dell'Immacolata (IDI-IRCCS) , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0300-8157","authenticated-orcid":false,"given":"Enzo","family":"Palese","sequence":"additional","affiliation":[{"name":"Surgery Department, Istituto Dermopatico dell'Immacolata (IDI-IRCCS) , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2524-7889","authenticated-orcid":false,"given":"Corrado","family":"Cirielli","sequence":"additional","affiliation":[{"name":"Unit of Vascular Surgery , IDI-IRCCS, Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2379-9471","authenticated-orcid":false,"given":"Guido","family":"Melillo","sequence":"additional","affiliation":[{"name":"Unit of Cardiology , IDI-IRCCS, Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1360-2700","authenticated-orcid":false,"given":"Daniele","family":"Avitabile","sequence":"additional","affiliation":[{"name":"IDI farmaceutici s.r.l., Pomezia, Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7601-321X","authenticated-orcid":false,"given":"Christine","family":"Nardini","sequence":"additional","affiliation":[{"name":"Istituto per le Applicazioni del Calcolo (IAC) , CNR, Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3635-7664","authenticated-orcid":false,"given":"Paolo","family":"Tieri","sequence":"additional","affiliation":[{"name":"Istituto per le Applicazioni del Calcolo (IAC) , CNR, Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8749-8232","authenticated-orcid":false,"given":"Fabrizio","family":"De Benedetti","sequence":"additional","affiliation":[{"name":"Department of Immunology, Laboratory of Immuno-Rheumatology, Bambino Ges\u00f9 Children's Hospital, IRCCS , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank M","family":"Longo","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurological Sciences Stanford University , Stanford, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9054-337X","authenticated-orcid":false,"given":"Alessandra","family":"Magenta","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Regenerative Medicine, Istituto Dermopatico dell\u2019Immacolata, IDI-IRCCS , Rome ,","place":["Italy"]},{"name":"Institute of Translational Pharmacology (IFT), National Research Council of Italy (CNR) , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1682-6371","authenticated-orcid":false,"given":"Luisa","family":"Bracci-Laudiero","sequence":"additional","affiliation":[{"name":"Department of Immunology, Laboratory of Immuno-Rheumatology, Bambino Ges\u00f9 Children's Hospital, IRCCS , Rome ,","place":["Italy"]},{"name":"Institute of Translational Pharmacology (IFT), National Research Council of Italy (CNR) , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"2026062312174431200_ljag152-B1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","article-title":"Advances in the pathogenesis of psoriasis: from keratinocyte perspective","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis"},{"key":"2026062312174431200_ljag152-B2","doi-asserted-by":"crossref","first-page":"1379490","DOI":"10.3389\/fimmu.2024.1379490","article-title":"The role of dermal fibroblasts in autoimmune skin diseases","volume":"15","author":"Shi","year":"2024","journal-title":"Front Immunol"},{"key":"2026062312174431200_ljag152-B3","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/1523-1747.ep12326689","article-title":"Nerve growth factor is increased in psoriatic skin","volume":"105","author":"Fantini","year":"1995","journal-title":"J Invest Dermatol"},{"key":"2026062312174431200_ljag152-B4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0079-6123(03)46027-5","article-title":"Role of NGF and neurogenic inflammation in the pathogenesis of psoriasis","volume":"146","author":"Raychaudhuri","year":"2004","journal-title":"Prog Brain Res"},{"key":"2026062312174431200_ljag152-B5","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/jcp.22811","article-title":"Role of neurotrophins on dermal fibroblast survival and differentiation","volume":"227","author":"Palazzo","year":"2012","journal-title":"J Cell Physiol"},{"key":"2026062312174431200_ljag152-B6","doi-asserted-by":"crossref","first-page":"721","DOI":"10.4103\/1673-5374.156967","article-title":"The p75 neurotrophin receptor: at the crossroad of neural repair and death","volume":"10","author":"Meeker","year":"2015","journal-title":"Neural Regen Res"},{"key":"2026062312174431200_ljag152-B7","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3390\/ijms18051028","article-title":"NGF and its receptors in the regulation of inflammatory response","volume":"18","author":"Minnone","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2026062312174431200_ljag152-B8","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.12688\/f1000research.8434.1","article-title":"Recent advances in understanding neurotrophin signaling","volume":"5","author":"Bothwell","year":"2016","journal-title":"F1000Res"},{"key":"2026062312174431200_ljag152-B9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2005.02143.x","article-title":"The intriguing biology of the tumour necrosis factor\/tumour necrosis factor receptor superfamily: players, rules and the games","volume":"115","author":"Hehlgans","year":"2005","journal-title":"Immunology"},{"key":"2026062312174431200_ljag152-B10","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.tips.2021.06.006","article-title":"In vivo functions of p75NTR: challenges and opportunities for an emerging therapeutic target","volume":"42","author":"Malik","year":"2021","journal-title":"Trends Pharmacol Sci"},{"key":"2026062312174431200_ljag152-B11","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4103\/1673-5374.380873","article-title":"Soluble p75 neurotrophic receptor as a reliable biomarker in neurodegenerative diseases: what is the evidence?","volume":"19","author":"Jourdi","year":"2024","journal-title":"Neural Regen Res"},{"key":"2026062312174431200_ljag152-B12","doi-asserted-by":"crossref","first-page":"818630","DOI":"10.3389\/fimmu.2022.818630","article-title":"Pro nerve growth factor and its receptor p75NTR activate inflammatory responses in synovial fibroblasts: a novel targetable mechanism in arthritis","volume":"13","author":"Farina","year":"2022","journal-title":"Front Immunol"},{"key":"2026062312174431200_ljag152-B13","doi-asserted-by":"crossref","first-page":"e000441","DOI":"10.1136\/rmdopen-2017-000441","article-title":"ProNGF\u2013p75NTR axis plays a proinflammatory role in inflamed joints: a novel pathogenic mechanism in chronic arthritis","volume":"3","author":"Minnone","year":"2017","journal-title":"RMD Open"},{"key":"2026062312174431200_ljag152-B14","doi-asserted-by":"crossref","first-page":"1305574","DOI":"10.3389\/fnmol.2023.1305574","article-title":"Immune activation of the p75 neurotrophin receptor: implications in neuroinflammation","volume":"16","author":"Danelon","year":"2023","journal-title":"Front Mol Neurosci"},{"key":"2026062312174431200_ljag152-B15","doi-asserted-by":"crossref","first-page":"e157002","DOI":"10.1172\/JCI157002","article-title":"Human immunomodulatory ligand B7-1 mediates synaptic remodeling via the p75 neurotrophin receptor","volume":"132","author":"Morano","year":"2022","journal-title":"J Clin Invest"},{"key":"2026062312174431200_ljag152-B16","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-95502-7.00028-2","volume-title":"Reference Module in Life Sciences","author":"Petti","year":"2024"},{"key":"2026062312174431200_ljag152-B17","doi-asserted-by":"crossref","first-page":"14984","DOI":"10.1038\/s41598-020-72061-z","article-title":"A comprehensive p75 neurotrophin receptor gene network and pathway analyses identifying new target genes","volume":"10","author":"Sajanti","year":"2020","journal-title":"Sci Rep"},{"key":"2026062312174431200_ljag152-B18","first-page":"1507","article-title":"Neuron-type-specific signaling by the p75NTR death receptor regulated by differential proteolytic cleavage","volume":"128","author":"Vicario","year":"2015","journal-title":"J Cell Sci"},{"key":"2026062312174431200_ljag152-B19","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/cdd.2010.162","article-title":"p75 neurotrophin receptor mediates apoptosis in transit-amplifying cells and its overexpression restores cell death in psoriatic keratinocytes","volume":"18","author":"Truzzi","year":"2011","journal-title":"Cell Death Differ"},{"key":"2026062312174431200_ljag152-B20","doi-asserted-by":"crossref","first-page":"1058862","DOI":"10.3389\/fimmu.2022.1058862","article-title":"Essential immune functions of fibroblasts in innate host defense","volume":"13","author":"Cavagnero","year":"2022","journal-title":"Front Immunol"},{"key":"2026062312174431200_ljag152-B21","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3892\/ijmm.2015.2146","article-title":"Toll-like receptor family members in skin fibroblasts are functional and have a higher expression compared to skin keratinocytes","volume":"35","author":"Yao","year":"2015","journal-title":"Int J Mol Med"},{"key":"2026062312174431200_ljag152-B22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00403-016-1620-4","article-title":"Association of Toll-like receptor 4 (TLR4) with chronic plaque type psoriasis and psoriatic arthritis","volume":"308","author":"Smith","year":"2016","journal-title":"Arch Dermatol Res"},{"key":"2026062312174431200_ljag152-B23","doi-asserted-by":"crossref","first-page":"812774","DOI":"10.3389\/fimmu.2022.812774","article-title":"Toll-like receptor signaling and its role in cell-mediated immunity","volume":"13","author":"Duan","year":"2022","journal-title":"Front Immunol"},{"key":"2026062312174431200_ljag152-B24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1468-3083.2011.04372.x","article-title":"Increased gene expression of Toll-like receptor 4 on peripheral blood mononuclear cells in patients with psoriasis","volume":"27","author":"Garcia-Rodriguez","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026062312174431200_ljag152-B25","doi-asserted-by":"crossref","first-page":"867813","DOI":"10.3389\/fcvm.2022.867813","article-title":"Extracellular nucleophosmin is increased in psoriasis and correlates with the determinants of cardiovascular diseases","volume":"9","author":"D\u2019Agostino","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2026062312174431200_ljag152-B26","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1039\/C3MB70242A","article-title":"Signalling pathway database usability: lessons learned","volume":"9","author":"Tieri","year":"2013","journal-title":"Mol Biosyst"},{"key":"2026062312174431200_ljag152-B27","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1038\/s41467-023-39020-4","article-title":"Single cell and spatial sequencing define processes by which keratinocytes and fibroblasts amplify inflammatory responses in psoriasis","volume":"14","author":"Ma","year":"2023","journal-title":"Nat Commun"},{"key":"2026062312174431200_ljag152-B28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/imr.12972","article-title":"Fibroblasts as confederates of the immune system","volume":"302","author":"Correa-Gallegos","year":"2021","journal-title":"Immunol Rev"},{"key":"2026062312174431200_ljag152-B29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/1523-1747.ep12388914","article-title":"Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes","volume":"103","author":"Pincelli","year":"1994","journal-title":"J Invest Dermatol"},{"key":"2026062312174431200_ljag152-B30","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1523\/JNEUROSCI.3547-05.2006","article-title":"Small, nonpeptide p75 NTR ligands induce survival signaling and inhibit proNGF-induced death","volume":"26","author":"Massa","year":"2006","journal-title":"J Neurosci"},{"key":"2026062312174431200_ljag152-B31","doi-asserted-by":"crossref","first-page":"D816","DOI":"10.1093\/nar\/gks1158","article-title":"The BioGRID interaction database: 2013 update","volume":"41","author":"Chatr-Aryamontri","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"2026062312174431200_ljag152-B32","doi-asserted-by":"crossref","first-page":"D691","DOI":"10.1093\/nar\/gkq1018","article-title":"Reactome: a database of reactions, pathways and biological processes","volume":"39","author":"Croft","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"2026062312174431200_ljag152-B33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/biom12010060","article-title":"HMGB-1 in psoriasis","volume":"12","author":"Casciaro","year":"2021","journal-title":"Biomolecules"},{"key":"2026062312174431200_ljag152-B34","doi-asserted-by":"crossref","first-page":"1569632","DOI":"10.3389\/fimmu.2025.1569632","article-title":"HMGB1: new biomarker and therapeutic target of autoimmune and autoinflammatory skin diseases","volume":"16","author":"Fan","year":"2025","journal-title":"Front Immunol"},{"key":"2026062312174431200_ljag152-B35","first-page":"149","volume-title":"ELISA. Methods in Molecular Biology","author":"Bagchi","year":"2015"},{"key":"2026062312174431200_ljag152-B36","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41590-023-01723-7","article-title":"Breaking NGF\u2013TrkA immunosuppression in melanoma sensitizes immunotherapy for durable memory T cell protection","volume":"25","author":"Yin","year":"2024","journal-title":"Nat Immunol"},{"key":"2026062312174431200_ljag152-B37","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.4049\/jimmunol.1300825","article-title":"Nerve growth factor downregulates inflammatory response in human monocytes through TrkA","volume":"192","author":"Prencipe","year":"2014","journal-title":"J Immunol"},{"key":"2026062312174431200_ljag152-B38","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1007\/s00125-019-4885-2","article-title":"Modulation of the p75 neurotrophin receptor using LM11A-31 prevents diabetes-induced retinal vascular permeability in mice via inhibition of inflammation and the RhoA kinase pathway","volume":"62","author":"Elshaer","year":"2019","journal-title":"Diabetologia"},{"key":"2026062312174431200_ljag152-B39","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bcp.2015.08.109","article-title":"Toll-like receptor 4 signaling: a \u00adcommon pathway for interactions between prooxidants and extracellular disulfide high mobility group box 1 (HMGB1) \u00adprotein-coupled activation","volume":"98","author":"Zhang","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"2026062312174431200_ljag152-B40","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/jdv.13564","article-title":"High mobility group box 1 is increased in the sera of psoriatic patients with disease progression","volume":"30","author":"Bergmann","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026062312174431200_ljag152-B41","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00403-013-1330-0","article-title":"Increased HMGB1 serum levels and altered HMGB1 expression in patients with psoriasis vulgaris","volume":"305","author":"Chen","year":"2013","journal-title":"Arch Dermatol Res"},{"key":"2026062312174431200_ljag152-B42","doi-asserted-by":"crossref","first-page":"e1205","DOI":"10.1002\/iid3.1205","article-title":"HMGB1 regulates Th17 cell differentiation and function in patients with psoriasis","volume":"12","author":"Zhu","year":"2024","journal-title":"Immunity Inflamm Dis"},{"key":"2026062312174431200_ljag152-B43","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/15548627.2020.1725381","article-title":"Autophagy-based uncon\u00adventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin in\ufb02ammation","volume":"17","author":"Wang","year":"2021","journal-title":"Autophagy"},{"key":"2026062312174431200_ljag152-B44","doi-asserted-by":"crossref","first-page":"11942","DOI":"10.1073\/pnas.1003893107","article-title":"A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release","volume":"107","author":"Yang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026062312174431200_ljag152-B45","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1089\/ars.2016.6966","article-title":"Nitration and glycation turn mature NGF into a toxic factor for motor neurons: a role for p75 NTR and RAGE signaling in ALS","volume":"28","author":"Kim","year":"2018","journal-title":"Antioxid Redox Signal"},{"key":"2026062312174431200_ljag152-B46","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/cc9990","article-title":"The role of receptor for advanced glycation endproducts (RAGE) in infection","volume":"15","author":"van Zoelen","year":"2011","journal-title":"Crit Care"},{"key":"2026062312174431200_ljag152-B47","doi-asserted-by":"crossref","first-page":"10123","DOI":"10.3389\/ebm.2024.10123","article-title":"LM11A-31, a modulator of p75 neurotrophin receptor, suppresses HIV-1 replication and inflammatory response in macrophages","volume":"249","author":"Mirzahosseini","year":"2024","journal-title":"Exp Biol Med"},{"key":"2026062312174431200_ljag152-B48","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3390\/ijms26010401","article-title":"ProBDNF as a myokine in skeletal muscle injury: role in inflammation and potential for therapeutic modulation of p75NTR","volume":"26","author":"Aby","year":"2025","journal-title":"Int J Mol Sci"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljag152\/68106770\/ljag152.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/195\/1\/122\/68106770\/ljag152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/195\/1\/122\/68106770\/ljag152.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:17:58Z","timestamp":1782231478000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/195\/1\/122\/8658288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,4,17]]},"published-print":{"date-parts":[[2026,6,23]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljag152","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,4,17]]}}}